Breast Cancer e-Support Program (Mobile Application) to improve symptom management, self-efficacy, social support, Quality of Life, anxiety and depression for Chinese Women with Breast Cancer Undergoing Chemotherapy

Not Applicable

Completed

• Conditions: breast cancer; Cancer - Breast

• Registration Number: ACTRN12616000639426
• Lead Sponsor: The University of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 106

Inclusion Criteria

(1) diagnosed with breast cancer within 3-8 weeks; (2) treated with curative intent surgery and adjuvant chemotherapy at the study sites; (3) able to access internet at home with computer or mobile phone; (4) cognitively and physically capable of participating and completing self-report questionnaire; (5) having a telephone and email address to contact for follow up; (6) able to speak and read Mandarin.

Exclusion Criteria

(1) having a concurrent major physical illness; (2) having a chronic mental health problem.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
self-efficacy: Stanford Inventory of Cancer Patient Adjustment (SICPA)[T0: baseline, before randomisation <br>T1: immediately after intervention;<br>T2: 12 weeks after intervention. ];Social support: Multidimensional Scale of Perceived Social Support (MSPSS)[T0: baseline, before randomisation <br>T1: immediately after intervention;<br>T2: 12 weeks after intervention. ]

Secondary Outcome Measures

Name	Time	Method
Symptom distress: M.D. Anderson Symptom Inventory (MDASI)[T0: baseline, before randomisation <br>T1: immediately after intervention;<br>T2: 12 weeks after intervention. ];Quality of life: Functional Assessment of Cancer Treatment-B (FACT-B)[T0: baseline, before randomisation <br>T1: immediately after intervention;<br>T2: 12 weeks after intervention. ];This is a composite secondary outcome<br>Anxiety and depression: Hospital Anxiety and Depression Scale (HADS) <br>[T0: baseline, before randomisation <br>T1: immediately after intervention;<br>T2: 12 weeks after intervention. ]